Goa-based Molbio Diagnostics recently announced an $85mn fund raise from Singapore’s Temasek at an enterprise value of $1.5 bn reportedly making it India’s first ‘unicorn’ in the medical devices sector. Its flagship Truenat is a relatively low-cost, portable and miniaturised polymerase chain reaction (PCR) technology platform or micro PCR. The platform takes molecular biology testing for life-threatening … Continue reading The point-of-care bet. In conversation with Molbio’s founders
Apothecurry 